Indications and Purposes
| 1 Indications And Usage Campath Is Indicated As A Single Agent For The Treatment Of B-Cell Chronic Lymphocytic Leukemia (B-Cll). Campath Is A Cd52-Directed Cytolytic Antibody Indicated As A Single Agent For The Treatment Of B-Cell Chronic Lymphocytic Leukemia (B-Cll). ( 1 ) |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Alemtuzumab |